| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Etomidate EP Impurity A |
依托咪酯雜質(zhì)A |
3157-27-5 |
詳細(xì)
|
| NDT 9513727 |
化合物 T24524 |
439571-48-9 |
詳細(xì)
|
| SIB-1553A |
SIB 1553A hydrochloride |
191611-89-9 |
詳細(xì)
|
| Keto Lovastatin |
酮洛伐他汀 |
96497-73-3 |
詳細(xì)
|
| UNC0646 |
N-(1-環(huán)己基-4-哌啶基)-2-[六氫-4-異丙基-1H-1,4-二氮雜卓-1-基]-6-甲氧基-7-[3-(1-哌啶基)丙氧基]-4-喹唑啉胺 |
1320288-17-2 |
詳細(xì)
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
詳細(xì)
|
| NOX-6-18 |
GPR132 ANTAGONIST 1 (NOX-6-18) |
898211-21-7 |
詳細(xì)
|
| MRS2179 tetrasodium |
CCPLITQNIFLYQB-UHFFFAOYSA-N |
1454889-37-2 |
詳細(xì)
|
| NBI 31772 |
NBI-31772 hydrate |
374620-70-9 |
詳細(xì)
|
| SM-276001 |
SM-276001 |
473930-22-2 |
詳細(xì)
|
| RS 39604 |
RS 39604鹽酸鹽 |
167710-87-4 |
詳細(xì)
|
| sulfosuccinimidyl oleate sodium |
磺基琥珀酰油酸酯(鈉鹽) |
1212012-37-7 |
詳細(xì)
|
| PD176252 |
(2S)-3-(1H-INDOL-3-YL)-N-[[1-(5-METHOXYPYRIDIN-2-YL)CYCLOHEXYL]METHYL]-2-METHYL-2-[(4-NITROPHENYL)CARBAMOYLAMINO]PROPANAMIDE |
204067-01-6 |
詳細(xì)
|
| 6-Methyl-2-thioxo-2,3-dihydro-1H-pyrrolo[2,3-d]pyrimidin-4(7H)-one |
6-METHYL-2-MERCAPTO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-OL |
97337-17-2 |
詳細(xì)
|
| FFN246 |
(FREEBASE) |
2210244-83-8 |
詳細(xì)
|
| PSB-603 |
8-[4-[4-(4-Chlorophenzyl)piperazide-1-sulfonyl)phenyl]]-1-propylxanthine |
1092351-10-4 |
詳細(xì)
|
| 15-keto Prostaglandin F2α |
15-KETO PROSTAGLANDIN F2ALPHA |
35850-13-6 |
詳細(xì)
|
| NA |
|
41828-97-8 |
詳細(xì)
|
| (R)-STU104 |
化合物 (R)-STU104 |
2767124-77-4 |
詳細(xì)
|
| 6,6'-Oxybis(2,2-dimethylhexanoic) acid |
183293-82-5 |
183293-82-5 |
詳細(xì)
|
| PF-06651600 malonate |
化合物 T5382L |
2140301-97-7 |
詳細(xì)
|
| MET kinase-IN-2 |
化合物 MET-KINASE-IN-2 |
2101241-90-9 |
詳細(xì)
|
| NTP-42 |
NTP-42 |
2055599-51-2 |
詳細(xì)
|
| Cyanine3 NHS ester |
|
1393427-85-4 |
詳細(xì)
|
| 1,2,3,9-Tetrahydro-8-methyl-2-thioxo-6H-purin-6-one |
1,2,3,9-四氫-8-甲基-2-硫氧代-6H-嘌呤-6-酮 |
91184-09-7 |
詳細(xì)
|
| ML-336 |
(E)-2-((1,4-二甲基哌嗪-2-亞基)氨基)-5-硝基-N-苯基苯甲酰胺 |
1613465-33-0 |
詳細(xì)
|
| SB 216641 hydrochloride |
SB216641 HYDROCHLORIDE |
193611-67-5 |
詳細(xì)
|
| Anhydrotetracycline |
(2Z,4S,4aS,12aS)-2-(amino-hydroxy-methylidene)-4-dimethylamino-10,11,1 2a-trihydroxy-6-methyl-4a,5-dihydro-4H-tetracene-1,3,12-trione |
1665-56-1 |
詳細(xì)
|
| Cy3 NHS ester |
CYANINE3 NHS ESTER |
1393363-07-9 |
詳細(xì)
|
| 2-mercapto-6-methylthieno[2,3-d]pyrimidin-4(3H)-one |
2-巰基-6-甲基噻吩并[2,3-D]嘧啶-4-醇 |
38201-63-7 |
詳細(xì)
|
| SKF-82958 hydrobromide |
SKF 82958 hydrobromide |
74115-01-8 |
詳細(xì)
|
| Coerulignone |
3,3',5,5'-四甲氧聯(lián)對苯醌 |
493-74-3 |
詳細(xì)
|
| BI-1622 |
化合物 BI-1622 |
2681392-19-6 |
詳細(xì)
|
| PF 03814735 |
N-[2-[(1S,4R)-6-[[4-(環(huán)丁基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1,2,3,4-四氫萘-1,4-亞氨-9-基]-2-氧代乙基]乙酰胺 |
942487-16-3 |
詳細(xì)
|
| KRpep-2d |
抑制劑多肽KRPEP-2D |
2098181-84-9 |
詳細(xì)
|
| STM3006 |
化合物 STM3006 |
2499664-52-5 |
詳細(xì)
|
| SR 3677 dihydrochloride |
SR 3677 DIHYDROCHLORIDE |
1781628-88-3 |
詳細(xì)
|
| UK-370106 |
(R)-3-((S)-1-((S)-2-methoxy-1-phenylethylamino)-3,3-dimethyl-1-oxobutan-2-ylcarbamoyl)-6-(2-methylbiphenyl-4-yl)hexanoic acid |
230961-21-4 |
詳細(xì)
|
| LIN28 inhibitor LI71 |
LIN28 INHIBITOR LI71 |
1357248-83-9 |
詳細(xì)
|
| Talibegron hydrochloride |
TALIBEGRON鹽酸鹽 |
178600-17-4 |
詳細(xì)
|
| S-3-hydroxyphenylglycine |
(S)-3-羥基苯甘氨酸 |
71301-82-1 |
詳細(xì)
|
| TL4-12 |
化合物 T26280 |
1620820-12-3 |
詳細(xì)
|
| LY88074 |
雷洛昔芬雜質(zhì)D |
177744-96-6 |
詳細(xì)
|
| AKT-IN-1 |
6-[4-(1-氨基環(huán)丁基)苯基]-5-苯基-3-吡啶甲酰胺 |
1357158-81-6 |
詳細(xì)
|
| GW604714X |
5-(5-(6-(4-乙?；哙?1-基)-3-硝基吡啶-2-基)-2-氟亞芐基)噻唑烷-2,4-二酮 |
853953-65-8 |
詳細(xì)
|
| DS-1971a |
DS-1971a |
1450595-86-4 |
詳細(xì)
|
| tert-Butyl 2-[2-(2-bromoethoxy)ethoxy]acetate |
乙酸叔丁酯-二聚乙二醇-溴代 |
1807518-63-3 |
詳細(xì)
|
| GOT1 inhibitor 2c |
N-(4-氯苯基)-4-(1H-吲哚-4-基)哌嗪-1-甲酰胺 |
732973-87-4 |
詳細(xì)
|
| D-I03 |
D-I03 |
688342-78-1 |
詳細(xì)
|
| SF2312 ammonium |
|
|
詳細(xì)
|
| SJ1008030 formic |
|
|
詳細(xì)
|
| TLR7/8 agonist 4 hydroxy-PEG6-acid hydrochloride |
|
|
詳細(xì)
|
| PROTAC BRD4 ligand-2 hydrochloride |
|
|
詳細(xì)
|
| ERAS-5024 |
|
|
詳細(xì)
|
| Cloretazine |
1,2-雙(甲磺酰基)-1-(2-氯乙基)-2-(甲氨羰基)肼 |
173424-77-6 |
詳細(xì)
|
| Liraglutide |
利拉魯肽 |
204656-20-2 |
詳細(xì)
|
| (±)-U-50488 hydrate hydrochloride |
化合物 T21830 |
114528-79-9 |
詳細(xì)
|
| Goserelin acetate |
醋酸戈舍瑞林 |
145781-92-6 |
詳細(xì)
|
| ZM226600 |
化合物 T23563 |
147695-92-9 |
詳細(xì)
|
| RS 67506 hydrochloride |
RS 67506 鹽酸鹽 |
168986-61-6 |
詳細(xì)
|
| Leuprorelin |
亮丙瑞林 |
53714-56-0 |
詳細(xì)
|
| PDD00031705 |
PDD00031705 |
2032096-45-8 |
詳細(xì)
|
| RMC-5552 |
RMC-5552 |
2382768-62-7 |
詳細(xì)
|
| AP1867 |
AP1867 |
195514-23-9 |
詳細(xì)
|
| Rheb inhibitor NR1 |
化合物 T16741 |
2216763-38-9 |
詳細(xì)
|
| GDC 0068 |
帕他色替 |
1001264-89-6 |
詳細(xì)
|
| Goserelin |
戈舍瑞林 |
65807-02-5 |
詳細(xì)
|
| 4-PPBP maleate |
化合物 T22513 |
201216-39-9 |
詳細(xì)
|
| LY294002 |
LY294002/PI3K抑制劑 |
154447-36-6 |
詳細(xì)
|
| Rigosertib sodium |
瑞格色替鈉 |
592542-60-4 |
詳細(xì)
|
| CX5461 |
CX-5461 |
1138549-36-6 |
詳細(xì)
|
| Benzamide, 4-amino-5-chloro-2-methoxy-N-[[1-[3-(1H-1,2,3-triazol-1-yl)propyl]-4-piperidinyl]methyl]- |
|
1342815-16-0 |
詳細(xì)
|
| Onatasertib/CC-223/ATG-008 |
|
1402453-64-8 |
詳細(xì)
|
| Lumicitabine |
化合物L(fēng)UMICITABINE |
1445385-02-3 |
詳細(xì)
|
| PDD00017238 |
|
1952247-05-0 |
詳細(xì)
|
| Manoalide |
MANOALIDE |
75088-80-1 |
詳細(xì)
|
| LX-1031 |
4-[2-氨基-6-[(1R)-2,2,2-三氟-1-(3'-甲氧基聯(lián)苯-4-基)乙氧基]嘧啶-4-基]-L-苯丙氨酸 |
945976-76-1 |
詳細(xì)
|
| MI-192 |
MI-192 |
1415340-63-4 |
詳細(xì)
|
| RN 1 dihydrochloride |
RN1; RN 1 |
1781835-13-9 |
詳細(xì)
|
| ZD 7114 hydrochloride |
ICI D7114 |
129689-28-7 |
詳細(xì)
|
| STO-609 acetate |
STO-609 (acetate) |
1173022-21-3 |
詳細(xì)
|
| PROTACPARP1degrader |
PROTAC PARP1 degrader |
2369022-68-2 |
詳細(xì)
|
| WAY 207024 dihydrochloride |
|
872002-73-8 |
詳細(xì)
|
| NPS-2143/SB-262470A hydrochloride) |
2-氯-6-[(2R)-3-[[1,1-二甲基-2-(2-萘基)乙基]氨基]-2-羥基丙氧基]苯腈鹽酸鹽 |
324523-20-8 |
詳細(xì)
|
| INCB086550 |
INCB084550 |
2230911-59-6 |
詳細(xì)
|
| PACMA 31 |
PACMA 31 |
1401089-31-3 |
詳細(xì)
|
| AX-15836 |
2035509-96-5 |
2035509-96-5 |
詳細(xì)
|
| Aucubin Impurity 4 (Bartsiosid) |
[(1S)-1β,4aβ,5,7aβ-Tetrahydro-7-(hydroxymethyl)cyclopenta[c]pyran-1-yl]β-D-glucopyranoside |
62133-72-6 |
詳細(xì)
|
| NNC 05-2090 |
化合物 T28183 |
184845-43-0 |
詳細(xì)
|
| SR27897 |
SR27897 |
136381-85-6 |
詳細(xì)
|
| Halofantrine Hydrochloride |
鹽酸鹵泛群 |
36167-63-2 |
詳細(xì)
|
| Cenisertib/AS-703569/R-763) |
R763(AS-703569) |
871357-89-0 |
詳細(xì)
|
| 2,4-dimethyl-5-[(1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-pyrrole-3-propanoic acid |
|
245036-27-5 |
詳細(xì)
|
| Meclocycline |
氯甲烯土霉素 |
2013-58-3 |
詳細(xì)
|
| Indirubin |
靛玉紅 |
397242-72-7 |
詳細(xì)
|
| Sagopilone |
沙戈匹隆 |
305841-29-6 |
詳細(xì)
|
| Plevitrexed |
普來曲塞 |
153537-73-6 |
詳細(xì)
|
| TMI 005 |
N-羥基-4-[[4-[(4-羥基-2-丁炔基)氧基]苯基]磺?；鵠-2,2-二甲基-3-硫代嗎啉甲酰胺 |
287405-51-0 |
詳細(xì)
|
| PD123319 Ditrifluoroacetate |
PD 123319 二(三氟乙酸鹽) |
136676-91-0 |
詳細(xì)
|
| Fulzerasib（IBI351; GFH925） |
|
2641747-54-6 |
詳細(xì)
|